PA8630001A1 - Prolina cci-779, produccion y usos de la misma, y sintesis enzimatica de dos etapas de prolina cci-779 y cci-779 - Google Patents
Prolina cci-779, produccion y usos de la misma, y sintesis enzimatica de dos etapas de prolina cci-779 y cci-779Info
- Publication number
- PA8630001A1 PA8630001A1 PA20058630001A PA8630001A PA8630001A1 PA 8630001 A1 PA8630001 A1 PA 8630001A1 PA 20058630001 A PA20058630001 A PA 20058630001A PA 8630001 A PA8630001 A PA 8630001A PA 8630001 A1 PA8630001 A1 PA 8630001A1
- Authority
- PA
- Panama
- Prior art keywords
- cci
- prolina
- same
- stages
- production
- Prior art date
Links
- 229960000235 temsirolimus Drugs 0.000 title abstract 5
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 title 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Chemical compound OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 title 2
- 230000002255 enzymatic effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 102000004882 Lipase Human genes 0.000 abstract 1
- 108090001060 Lipase Proteins 0.000 abstract 1
- 239000004367 Lipase Substances 0.000 abstract 1
- 230000021736 acetylation Effects 0.000 abstract 1
- 238000006640 acetylation reaction Methods 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 235000019421 lipase Nutrition 0.000 abstract 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 abstract 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 abstract 1
- 229960002930 sirolimus Drugs 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 229920001567 vinyl ester resin Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
SE DESCRIBEN METODOS PARA LA SINTESIS DE CCI-799 Y PROLINA-CCI-779, INCLUYENDO UN METODO QUE INVOLUCRA ACETILACION CATALIZADA POR LIPASA DE 42-HIDROXI DE RAPAMICINA CON UN VINILESTER DE ACIDO 2,2-BIS(HIDROXIMETIL)PROPIONICO EN UN SOLVENTE ORGANICO SEGUIDO POR DESPROTECCION. ASIMISMO SE PROVEEN PRODUCTOS QUE CONTIENEN PROLINA-CCI-779 Y USO DE LA MISMA
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56206904P | 2004-04-14 | 2004-04-14 | |
US62359404P | 2004-10-29 | 2004-10-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8630001A1 true PA8630001A1 (es) | 2006-06-02 |
Family
ID=34968422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20058630001A PA8630001A1 (es) | 2004-04-14 | 2005-04-13 | Prolina cci-779, produccion y usos de la misma, y sintesis enzimatica de dos etapas de prolina cci-779 y cci-779 |
Country Status (13)
Country | Link |
---|---|
US (1) | US7202256B2 (es) |
EP (1) | EP1751168A1 (es) |
JP (1) | JP2007532650A (es) |
AR (1) | AR048603A1 (es) |
AU (1) | AU2005233612A1 (es) |
BR (1) | BRPI0509854A (es) |
CA (1) | CA2564811A1 (es) |
MX (1) | MXPA06011883A (es) |
PA (1) | PA8630001A1 (es) |
PE (1) | PE20060335A1 (es) |
SV (1) | SV2005002082A (es) |
TW (1) | TW200533673A (es) |
WO (1) | WO2005100366A1 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE385795T1 (de) | 2002-07-30 | 2008-03-15 | Wyeth Corp | Parenterale formulierungen mit einem rapamycin hydroxyester |
DE602005010228D1 (de) * | 2004-04-14 | 2008-11-20 | Wyeth Corp | Verfahren zur herstellung von rapamycin-42-estern und fk-506-32-estern mit dicarbonsäure, vorstufen für rapamycinkonjugate und antikörper |
CN1946852A (zh) * | 2004-04-27 | 2007-04-11 | 惠氏公司 | 利用雷帕霉素特异性甲基化酶标记雷帕霉素 |
JP2008517874A (ja) * | 2004-08-10 | 2008-05-29 | ワイス | Cci−779誘導体及びそれらの作製法 |
WO2007056175A2 (en) * | 2005-11-04 | 2007-05-18 | Wyeth | 41-methoxy isotope labeled rapamycin 42-ester |
WO2007067560A2 (en) | 2005-12-07 | 2007-06-14 | Wyeth | Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate |
PE20071067A1 (es) * | 2005-12-20 | 2007-11-26 | Wyeth Corp | Composiciones de rapamicina y cci-779 y metodo para su preparacion |
US20080175887A1 (en) | 2006-11-20 | 2008-07-24 | Lixiao Wang | Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs |
US8425459B2 (en) | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
US20080276935A1 (en) | 2006-11-20 | 2008-11-13 | Lixiao Wang | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
US9700704B2 (en) | 2006-11-20 | 2017-07-11 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US9737640B2 (en) | 2006-11-20 | 2017-08-22 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8998846B2 (en) | 2006-11-20 | 2015-04-07 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US8430055B2 (en) | 2008-08-29 | 2013-04-30 | Lutonix, Inc. | Methods and apparatuses for coating balloon catheters |
US8414526B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids |
US8414910B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8414525B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
TW200845960A (en) * | 2007-04-05 | 2008-12-01 | Wyeth Corp | Wortmannin-rapalog conjugate and uses thereof |
CL2009000844A1 (es) * | 2008-04-11 | 2009-06-12 | Galaxy Biotech Llc | Metodo para tratar cancer en un paciente que comprende la administracion de un primer agente que es inhibidor de factor de crecimiento de hepatocito (hgf) en combinacion con un segundo agente que es agonista de pten. |
EP2480557A2 (en) | 2009-09-25 | 2012-08-01 | Cadila Healthcare Limited | Process for the preparation of rapamycin derivatives |
AU2011260016B2 (en) | 2010-06-02 | 2013-08-22 | Fresenius Kabi Oncology Ltd. | Stable pharmaceutical compositions of Rapamycin esters |
CN102020662B (zh) | 2011-01-07 | 2013-02-13 | 天津市炜杰科技有限公司 | 一种驮瑞塞尔制备方法 |
WO2012131019A1 (en) | 2011-04-01 | 2012-10-04 | Sandoz Ag | Regioselective acylation of rapamycin at the c-42 position |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA737247B (en) | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
CA2106034A1 (en) | 1992-09-24 | 1994-03-25 | Ralph J. Russo | 21-norrapamycin |
US5362718A (en) | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
GB9710962D0 (en) * | 1997-05-28 | 1997-07-23 | Univ Cambridge Tech | Polyketides and their synthesis |
TWI256395B (en) | 1999-09-29 | 2006-06-11 | Wyeth Corp | Regioselective synthesis of rapamycin derivatives |
US6277983B1 (en) * | 2000-09-27 | 2001-08-21 | American Home Products Corporation | Regioselective synthesis of rapamycin derivatives |
ATE385795T1 (de) | 2002-07-30 | 2008-03-15 | Wyeth Corp | Parenterale formulierungen mit einem rapamycin hydroxyester |
ATE413163T1 (de) | 2002-09-17 | 2008-11-15 | Wyeth Corp | Granulierte formulierung des rapamycinesters ccl- 779 |
CN1829722B (zh) | 2003-08-07 | 2010-10-27 | 惠氏公司 | 区域选择性合成cci-779 |
-
2005
- 2005-04-12 BR BRPI0509854-8A patent/BRPI0509854A/pt not_active IP Right Cessation
- 2005-04-12 EP EP05744572A patent/EP1751168A1/en not_active Withdrawn
- 2005-04-12 WO PCT/US2005/012030 patent/WO2005100366A1/en not_active Application Discontinuation
- 2005-04-12 JP JP2007508408A patent/JP2007532650A/ja not_active Withdrawn
- 2005-04-12 MX MXPA06011883A patent/MXPA06011883A/es active IP Right Grant
- 2005-04-12 CA CA002564811A patent/CA2564811A1/en not_active Abandoned
- 2005-04-12 AU AU2005233612A patent/AU2005233612A1/en not_active Withdrawn
- 2005-04-12 US US11/103,779 patent/US7202256B2/en not_active Expired - Fee Related
- 2005-04-13 AR ARP050101448A patent/AR048603A1/es unknown
- 2005-04-13 PE PE2005000408A patent/PE20060335A1/es not_active Application Discontinuation
- 2005-04-13 PA PA20058630001A patent/PA8630001A1/es unknown
- 2005-04-13 TW TW094111636A patent/TW200533673A/zh unknown
- 2005-04-13 SV SV2005002082A patent/SV2005002082A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2564811A1 (en) | 2005-10-27 |
WO2005100366A1 (en) | 2005-10-27 |
US7202256B2 (en) | 2007-04-10 |
JP2007532650A (ja) | 2007-11-15 |
AU2005233612A1 (en) | 2005-10-27 |
EP1751168A1 (en) | 2007-02-14 |
AR048603A1 (es) | 2006-05-10 |
TW200533673A (en) | 2005-10-16 |
PE20060335A1 (es) | 2006-05-25 |
US20050234086A1 (en) | 2005-10-20 |
SV2005002082A (es) | 2005-12-13 |
BRPI0509854A (pt) | 2007-10-23 |
MXPA06011883A (es) | 2006-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8630001A1 (es) | Prolina cci-779, produccion y usos de la misma, y sintesis enzimatica de dos etapas de prolina cci-779 y cci-779 | |
CR20110483A (es) | Preparacion de pregabalina y compuestos relacionados (divisional de expediente 8765) | |
BRPI0707229B8 (pt) | método para produzir um l-aminoácido | |
PA8629901A1 (es) | Sintesis regioespecifica de derivados de 42-ester de rapamicina | |
MX344588B (es) | Produccion de acidos grasos y derivados de los mismos. | |
ECSP077271A (es) | Derivados de pirimidina | |
BR9712538A (pt) | Plantas transgênicas como uma fonte alternativa de enzimas degradadoras lignocelulósicas | |
BR112012017267A2 (pt) | ácidos graxos de cadeia ramificada dispersos e produção biológica dos mesmos | |
GB2390417A (en) | Target system | |
SG132661A1 (en) | Illumination system | |
WO2004099363A3 (en) | Dermal micro organs, methods and apparatuses for producing and using the same | |
RS20050431A (en) | Method for producing 1-olefins by catalytically splitting 1- alkoxyalkanes | |
BRPI0318811B8 (pt) | derivados de ciclohexanol espirocíclicos | |
BR9814521B1 (pt) | processo para a obtenção de uma cultura de microorganismo de gênero eubacterium, bem como o uso da mesma, aditivo para gênero alimentìcio, e uso do mesmo. | |
EP2295556A3 (en) | Lipolytic enzymes variants and methods for their production | |
AU2002246702A1 (en) | Method of screening for gpr40 ligands | |
EP2314571A3 (en) | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents | |
UY28912A1 (es) | Procedimiento para la preparación de derivados de 1,4-difenilazetidinona | |
ATE465355T1 (de) | Zweiachsantriebsanordnung | |
NL1024496A1 (nl) | Uit Fischer-Tropsch verkregen brandstof met een lage toxiciteit en een werkwijze voor de bereiding daarvan. | |
WO2001091763A3 (en) | Extracts from spermatophyte plants with antitumor activity | |
BR9807936A (pt) | Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação | |
DE502005009179D1 (de) | Leitschaufelring einer Strömungsmaschine und zugehöriges Modifikationsverfahren | |
BR9713370A (pt) | Processos para fabricação de metoprolol e de uma preparação farmacêutica, e, metoprolol | |
BR9809316A (pt) | Preparação de isoflavonas a partir deleguminosas |